Endo International (ENDP): Heavy Pre-Market Activity

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Endo International ( ENDP) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Endo International as such a stock due to the following factors:

  • ENDP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $120.5 million.
  • ENDP traded 201,673 shares today in the pre-market hours as of 9:18 AM, representing 14.1% of its average daily volume.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ENDP with the Ticky from Trade-Ideas. See the FREE profile for ENDP NOW at Trade-Ideas

More details on ENDP:

Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Currently there are 11 analysts that rate Endo International a buy, no analysts rate it a sell, and 4 rate it a hold.

The average volume for Endo International has been 2.3 million shares per day over the past 30 days. Endo International has a market cap of $15.0 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.21 and a short float of 6.7% with 7.23 days to cover. Shares are up 17.3% year-to-date as of the close of trading on Thursday.

If you liked this article you might like

Illumina Shares Spike on Strong Earnings, Upside Still Remains: Biotech Movers

Geron Shares Take a Dive After J&J Unit-Led Trial Falters; Endo Closes Higher: Biotech Movers

Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis

Canadian Pharma Goes Before FDA Panel Wednesday on Tamper Resistant Opioid

3 Biotech Stocks on Readers' Minds